Oliver Lagore Vanvalin Investment Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-90
| Closed | -$11.2K | – | 722 |
|
2024
Q3 | $11.2K | Hold |
90
| – | – | ﹤0.01% | 407 |
|
2024
Q2 | $14.2K | Hold |
90
| – | – | ﹤0.01% | 374 |
|
2024
Q1 | $11.7K | Hold |
90
| – | – | ﹤0.01% | 394 |
|
2023
Q4 | $8.68K | Sell |
90
-7
| -7% | -$675 | ﹤0.01% | 433 |
|
2023
Q3 | $11.8K | Buy |
97
+7
| +8% | +$849 | ﹤0.01% | 410 |
|
2023
Q2 | $10.3K | Hold |
90
| – | – | ﹤0.01% | 454 |
|
2023
Q1 | $12.4K | Hold |
90
| – | – | 0.01% | 355 |
|
2022
Q4 | $11.7K | Hold |
90
| – | – | 0.01% | 342 |
|
2022
Q3 | $10K | Hold |
90
| – | – | 0.01% | 342 |
|
2022
Q2 | $7K | Hold |
90
| – | – | ﹤0.01% | 380 |
|
2022
Q1 | $7K | Buy |
+90
| New | +$7K | ﹤0.01% | 381 |
|